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SUMMARY – Pandemic influenza A virus (H1N1) 2009 causes a disease that is epidemiologi-
cally and clinically not significantly different from seasonal influenza, but there are differences. The 
aim of the study was to display and compare epidemiological and clinical characteristics of pandemic 
influenza in children. At Dr. Fran Mihaljević University Hospital for Infectious Diseases in Zagreb, 
in the first two seasons, the incidence of pandemic influenza virus A (H1N1) in particular was exhaus-
tively analyzed only in patients with laboratory-confirmed pandemic influenza A virus (H1N1) 2009. 
In hospitalized children with documented influenza pandemic, moderate form of the disease pre-
dominated, which ultimately meant shorter hospital stay and fewer complications. Otitis media was 
the rarest complication in children in both seasons. In conclusion, children younger than 5 years, 
 especially boys, were vulnerable groups for pandemic influenza, presenting as a mild disease with low 
mortality and few complications. Most of the affected children with influenza did not have important 
risk factors such as asthma and obesity, highlighted by other authors as significant risk factors.
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Introduction
Influenza (caused by the influenza viruses A, B and 
C) as the most serious viral disease of the respiratory 
system is registered in 80,000 to 100,000 patients per 
year on average in Croatia and in 22,000 patients in 
the Federation of Bosnia and Herzegovina1-3. Influ-
enza rapidly spreads among humans as a droplet infec-
tion4. The patient is contagious for 5 to 7 days, i.e. two 
days before the onset of symptoms until the end of 
temperature elevation, and the immune compromised 
patients can shed virus for up to three weeks5-8. Most 
people infected with pandemic virus have a very mild 
form of the disease, but sometimes it results in serious 
and fatal disease causing destruction of numerous or-
gan system functions9-14. Pandemic virus, apart from 
complications in the respiratory system, causes com-
plications in other systems as well, such as various neu-
rological syndromes, myocardial degeneration, kidney 
damage, liver damage, joint damage, etc. It rarely 
causes secondary bacterial infection9,10,15,16. In children, 
signs of severe disease include apnea, tachypnea, dys-
pnea, cyanosis, dehydration, altered mental status, and 
extreme irritability17,18. In children hospitalized for in-
fluenza, neurological complications are frequent and 
sometimes life-threatening. In an effort to assess the 
extent and range of such complications in this popula-
tion, Australian researchers conducted a study includ-
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ing 506 children younger than 15 years with laborato-
ry-confirmed pandemic influenza A (H1N1) 2009 
infection (pH1N1’09) in six pediatric reference cen-
ters. Out of 506 patients, 49 (9.7%) had neurological 
complications. Patients with neurological complica-
tions were older (median age 4.8, range 0.5-12.6 years) 
compared with 3.7 (0.01-14.9 years) in those without 
complications. Encephalitis or encephalopathy was 
present in 1.4%, confusion in 1.0%, loss of conscious-
ness in 1.0%, and paralysis and Guillain-Barré syn-
drome in 0.4% of patients; 30.6% of patients were 
treated at the Intensive Care Unit (ICU) and 24.5% 
required mechanical ventilation. The mean length of 
hospital stay was 6.5 days and 49 patients died18. In 
September 2009, the World Health Organization 
(WHO) approved the only valid test for influenza di-
agnosis, and it is supported by reverse transcriptase 
polymerase chain reaction (RT-PCR), which has supe-
rior sensitivity and differentiation of subtypes and en-
ables phylogenetic analysis19-21. Based on clinical fea-
tures such as chronic diseases, risk factors, dyspnea, the 
physician can anticipate the possible development of 
severe forms of the disease, which is useful for clinical 
decision on patient treatment22. However, most people 
infected with pandemic influenza virus have a very 
mild form of the disease1,10,23. The mortality rate varies 
from study to study, depending on the type of study 
including patient profile, and ranges from 3% to 45%24-
26. In this pandemic, there are various pulmonary com-
plications and extrapulmonary complications such as 
myositis, kidney damage, pericarditis, reactive arthritis, 
myocardial infarction; sometimes there are fatal dis-
ease forms with collapse of many organ systems, re-
sulting in greater lethality13,15,24-27. There is particular 
connection of pandemic virus A (H1N1) 2009 with a 
large number of primary viral pneumonia cases among 
younger patients, which appears at the beginning of 
the disease with very fast development and often ac-
companied by acute respiratory distress syndrome 
(ARDS) and bacterial pneumonia as a complica-
tion15,27. In pandemic influenza, there is a number of 
neurological complications such as epileptic seizures, 
Reye’s syndrome, Guillain-Barré syndrome, cerebelli-
tis, transverse myelitis, acute necrotizing encephalopa-
thy, myelopathy and acute encephalitis, and postinfec-
tion encephalitis (acute disseminating encephalomy-
elitis, ADEM)27-30.
Patients and Methods
Based on the prospective monitoring of numerous 
parameters at Dr. Fran Mihaljević University Hospital 
for Infectious Diseases (UHID) in Zagreb, Croatia, 
demographic, epidemiological, clinical and basic labo-
ratory indicators of 64 children hospitalized with con-
firmed influenza A (pH1N1’09) virus infection diag-
nosis between July 1, 2009 and March 31, 2010 (pan-
demic season) were retrospectively analyzed. The same 
set of data was collected and analyzed for 44 children 
hospitalized for influenza A (pH1N1’09) virus infec-
tion in the subsequent season, from November 15, 
2010 to March 31, 2011 (post-pandemic season). Pa-
tient data were collected from medical records. The 
patients were stratified according to age, sex, date of 
admission to the hospital, duration of the disease pre-
ceding hospitalization (in days), and length of hospital 
stay (in days). Symptoms of the disease including their 
severity, complications and final outcome, risk factors, 
basic laboratory results (together with chest radio-
graphs), and applied treatment were analyzed. Ethical 
approval was obtained from the Ethics Committee of 
Dr. Fran Mihaljević University Hospital for Infectious 
Diseases from Zagreb.
Classification of disease severity
Disease severity was classified into four categories 
(internal coding) according to clinical presentation, 
accompanying chronic diseases, complications, and fi-
nal outcome, as follows: (1) mild (as a rule, without 
complications and chronic diseases); (2) moderate 
(complications and/or aggravation of chronic diseas-
es); (3) severe (treated at ICU); and (4) very severe (fa-
tal outcome). Risk factors and complications due to 
influenza A (pH1N1’09) were defined according to 
the International Classification of Diseases-10th Revi-
sion (ICD-10) and UHID internal coding. Due to its 
importance, diabetes was classified as an exceptional 
risk factor. The term encephalopathy was used gener-
ally for all disorders of consciousness, including pri-
mary and secondary affection of the central nervous 
system.
Laboratory testing
Clinical criteria for diagnosing influenza were pre-
senting symptoms (high fever, headache, fatigue, mus-
cle and joint aches, cough), together with indicative 
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(highest recorded values) laboratory tests (C-reactive 
protein [CRP], erythrocyte sedimentation rate [ESR], 
leukocyte count [L]), and epidemiological data. Labo-
ratory testing with basic biochemical analysis (blood 
glucose level, urea, creatinine, liver enzymes [AST, 
ALT, GGT, LDH]) was performed in all patients, and 
creatine kinase (CK) was analyzed in half of the pa-
tients using Olympus AU640 and/or Olympus AU400 
automated biochemistry analyzers (Hamburg, Ger-
many). All patients underwent chest radiography and 
85% of them electrocardiography (ECG). Any devia-
tion from normal electrocardiogram, with or without 
pharmacological treatment, was considered as a sign of 
pathologic ECG.
Respiratory samples (pharyngeal swab and/or 
bronchoalveolar aspirate) were analyzed and tested us-
ing RT-PCR in the Croatian National Influenza Cen-
tre, which exchanges information with the Influenza 
Centre in London31.
Statistical analysis
Statistical analysis included Kolmogorov-Smirnov 
test to assess equality of the distribution of continuous 
variables. To describe their grouping and dispersion, 
median and interquartile range were used for distribu-
tion of data that deviated significantly from the nor-
mal. The two asymmetrically distributed independent 
variables were compared using Mann-Whitney U test. 
To analyze difference in the proportions of nominal 
and ordinal variables, the χ2-test was used, and in the 
lack of expected frequency, Fisher exact test was addi-
tionally applied. The probability of error was set at 
α<0.05, and differences between the groups were ac-
cepted as statistically relevant at p<0.05. Statistical 
analysis was performed using SPSS software version 
17.0 and Microsoft Excel version 1132.
Results
Epidemiological features of pandemic influenza 
and differences in the incidence in the first two seasons 
in Croatia are shown in Table 1. During the pandemic 
season, there were 64 (37.9%) hospitalized children 
aged ≤18 years with proven influenza A virus, whereas 
during the post-pandemic season there were 44 (26%) 
hospitalized children (χ2-test=5.113, df=1, p<0.023).
Distribution of hospitalized children with con-
firmed influenza A (pH1N1’09) according to age 
groups in the first two seasons is shown in Table 2. In 
the pandemic season, children aged 7-14 were most 
commonly affected, with 21 (12.4%) cases in children. 
In the post-pandemic season, there were 13 (7.8%) 
cases aged 0-12, precisely 3-6 years.
Clinical and laboratory features of children with 
influenza A H1N1pdm09 virus infection during pan-
demic and post-pandemic seasons are shown in Table 
3. In the pandemic and post-pandemic seasons, the 
mean age of hospitalized children (0-17 age group) 
was 4.5±8.0 and 3.5±7.0 years, respectively (Mann-
Whitney U=1174.00, p=0.140). In the first season, 
Table 1. Epidemiological features of influenza A 
(pH1N1’09) virus infection during pandemic  




Outbreak July 2009 December 2010
Duration  
of the epidemic 9 months 4 months
Peak of the epidemic November 2009 January 2011
Number of examined 
/hospitalized 3856/562 2883/458
Hospitalized with 
confirmed infection 169 167







Died with confirmed 
infection: n (%) 4 (2.4) 9 (5.3)
Mean age of 
deceased (yrs) 35.3±7.8 44.7±16.3
Table 2. Age distribution of children with influenza A 




Pandemic season Post-pandemic season
n (%) n (%)
<1 11 6.5 13 7.8
1-2 12 7.1 7 4.2
3-6 16 9.5 13 7.8
7-14 21 12.4 9 5.4
15-17 4 2.4 2 1.2
Total 64 37.9 44 26.4
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there were 37 (57.8%) boys and 27 (42.2%) girls, 11 
(17.2%) of them infants. In the second season, there 
were 27 (61.4%) boys and 17 (38.6%) girls, 13 (29.5%) 
of them infants.
In the first season, the mean duration of the disease 
before hospitalization was 3.0±1.0 (range 1-7) days, 
whereas in the second season it was 4.0±3.0 (range 
1-11) days, which was statistically significant (Mann-
Whitney U=837.00, p<0.001).
The mean length of hospital stay in children with 
pandemic influenza virus A was 4.0±3.0 (range 1-33) 
days in the pandemic season and 6.0±3.0 (range 2-26) 
days in the post-pandemic season, which also was sta-
tistically significant (Mann-Whitney U=990.00, 
p<0.013). The mean highest body temperature in hos-
pitalized children and mean ESR are shown in Table 3.
The mean leukocyte count on children admission 
to the hospital was 8.5±4.9x109/L (range 0.9 to 
55.7x109/L) in the pandemic season and 9.5±9.3x109/L 
(range 1.8 to 34.0x109/L) in the post-pandemic season 
(Mann-Whitney U=1295.00; p=0.480). The mean 
CRP value in the pandemic season was 46.6±55.7 
(range 0.3 to 496) mg/L and 48.7±61.0 (range 0.1 to 
190) mg/L in the post-pandemic season (Mann-
Whitney U=1373.00; p=0.827).
In the pandemic season, CK was determined in 
14/64 children, with the mean value of 91.0±75.0 
(range 5-476) U/L. In the post-pandemic season, CK 
was determined in 18/44 children, with the mean val-
ue of 134.0±246.0 (range 32-877) U/L (Mann-Whit-
ney U=70.00; p=0.374). Although the CK value was 
considerably higher in the post-pandemic season, the 
difference was not statistically significant. Liver dam-
age was recorded in 6/64 (9.4%) children in the pan-
demic season and in 7/44 (15.9%) children in the 
post-pandemic season (χ²-test=0.485, df=1, p=0.486, 
Fisher exact test).
Abnormal ECG findings were reported more fre-
quently in children in the first season (18/144; 12.5%) 
as compared to the second season (14/150; 9.3%), 
however, without statistically significant difference (χ² 
test=3.175, df=1, p=0.075, Fisher exact test).
In the pandemic season, 43/64 (67.2%) hospital-
ized children were treated with oseltamivir. In the 
Table 3. Clinical and laboratory features of children with influenza A (pH1N1’09) virus infection during pandemic 
and post-pandemic seasons
Pandemic season Post-pandemic season





Mean age (yrs) 4.5 [8] 3.5 [7] 0.140
Duration of disease prior to hospitalization (days) 3.0 [1] 4.0 [3] 0.001*
Length of hospital stay (days) 4.0 [3] 6.0 [3] 0.013*
Mean maximum temperature (ºC) 39.5 [0.8] 39[0.8] 0.276
Erythrocyte sedimentation rate (mm/h) 15 [14] 20 [28] 0.326
Leukocyte count (x109/L) 8.5 [4.9] 9.5 [9.3] 0.480
C-reactive protein (mg/L) 46.6 [55.7] 48.7 [61.0] 0.827
Creatine kinase (U/L) 91 [75] 134 [246] 0.374
Laboratory findings n (%) n (%) p (χ²)
Liver damage 6 (9.4) 7 (15.9) 0.486
Abnormal electrocardiography 18 (28.2) 14 (31.8) 0.075
Patients treated with antiviral agents 43 (67.2) 36 (81.8) 0.092
Patients treated with antibiotics 23 (35.9) 21 (47.7) 0.220
Patients treated in Intensive Care Unit 13 (20.3) 4 (9.1) 0.220
Died 0 1 (2.3%) 0.226
Total 64 (37.9%) 44 (26.4%)
*Statistically significant (p<0.05)
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post-pandemic season, 36/44 (81.8%) children were 
administered oseltamivir. Compared to the pandemic 
season, the majority of children were treated with osel-
tamivir in the post-pandemic season, with no statisti-
cally significant difference (χ²-test=2.842, df=1, p= 
0.092, Fisher exact test). Antibiotics were used in 
23/64 (35.9%) hospitalized children in the first season 
and in 21/44 (47.7%) children in the second season 
(χ²-test=1.501, df=1, p=0.220, Fisher exact test). In the 
ICU, 13 (20.3%) children with proven virus were 
treated with antibiotics in the first season and four 
(9.1%) children in the second season (χ²-test=1.503, 
df=1, p=0.220, Fisher exact test) (Table 3).
Disease severity in children with influenza A 
(pH1N1’09) virus infection during the pandemic and 
post-pandemic seasons is shown in Table 4. In the first 
season, there were no children with very severe disease, 
whereas there were three (6.8%) such cases in the sec-
ond season, which was significantly higher (χ²=4.419, 
df=1, p<0.036, Fisher exact test) (Table 4).
Risk factors in children with influenza A (pH1N1’09) 
virus infection during the pandemic and post-pandemic 
seasons are shown in Table 5.
Table 6. Distribution of complications in children  
with influenza A (pH1N1’09) virus infection during 






n (%) n (%)
Primary viral 
pneumonia 10 (15.6) 6 (3.6) 0.774
Bacterial 
pneumonia 8 (12.5) 10 (22.7) 0.160
Liver damage 6 (9.4) 5 (11.4) 0.736
Myositis 7 (10.9) 2 (4.5) 0.237
Encephalopathy 4 (6.3) 2 (4.5) 0.704
Acute 
bronchitis 4 (6.3) - 0.091





- 1 (2.3) 0.225
Sinusitis 4 (6.3) 2 (4.5) 0.704
Febrile 
convulsions 5 (7.8) 2 (4.5) 0.498
Otitis media 2 (3.1) 1 (2.3) 0.791
Bronchiolitis 2 (3.1) 4 (9.1) 0.170
Other 
complications 9 (14) 7 (15.9) 0.791
Total 61 44
Table 4. Disease severity in children with influenza A 








n (%) n (%)
Mild 19 (29.7) 6 (13.6) 0.987
Moderate 32 (50.0) 32 (50.0) 0.651
Severe 13 (20.3) 3 (6.8) 0.846
Very severe 0 3 (6.8) 0.036*
Total 64 44
*Statistically significant (p<0.05)
Table 5. Risk factors in children with influenza A 








n (%) n (%)
Chronic heart 
disease 4 (6.25) 1 (2.3) 0.338





4 (6.25) 0 0.091
Hypertension 1 (1.5) 3 (6.8) 0.228
Immunological 
disorder 6 (9.4) 8 (18.2) 0.180
Malignant 
disease 1 (1.5) 1 (2.3) 0.788
Chronic kidney 
disease 1 (1.5) 0 0.404
Neuromuscular 
disease 9 (14) 2 (4.5) 0.102
Diabetes 
mellitus 1 (1.5) 1 (2.3) 0.788
Obesity 1 (1.5) 1 (2.3) 0.404
Congenital 
deformity 5 (7.8) 3 (6.8) 0.845
Total 39 (60.9) 23 (52.3)
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In the pandemic season, there were 27/64 (42.2%) 
children with risk factors and 37/64 (57.8%) without 
risk factors. In the post-pandemic season, there were 
34 (77.3%) children without risk factors and only 10 
(22.7%) with risk factors. In 27/64 (42.2%) children 
with confirmed influenza A (pH1N1’09) hospitalized 
in the pandemic season, there were 39 risk factors or a 
mean of 1.4 risk factors per patient. In 10/44 (22.7%) 
children hospitalized in the post-pandemic season, 
there were 23 risk factors or a mean of 2.3 risk factors 
per patient.
A significantly higher number of risk factors were 
recorded in hospitalized children in the pandemic sea-
son compared to the post-pandemic season (χ²-
test=4.383, df=1, p<0.036, Fisher exact test). Neuromus-
cular diseases were most common, found in 9/64 
(14.1%) children, followed by asthma and damage to 
the immune system in 6/64 (9.4%), congenital deformi-
ties in 5/64 (7.8%), and chronic heart disease and ob-
structive pulmonary disease in 4/64 (6.3%) children. In 
the post-pandemic season, the most common risk factor 
in hospitalized children was immunodeficiency in 8/44 
(18.2%) children, followed by hypertension, asthma and 
congenital deformities in 3/44 (6.8%) and neuromuscu-
lar disease in 2/44 (4.5%) children. There was no statis-
tically significant difference (χ2-test=14.547, df=10, 
p=0.149, Fisher exact test) in the occurrence of risk fac-
tors in hospitalized children with pandemic influenza 
between the two seasons (Table 5).
Distribution of complications in the children with 
influenza A (pH1N1’09) virus infection during the 
pandemic and post-pandemic seasons is shown in Ta-
ble 6. In the pandemic season, there were 35/64 
(54.7%) hospitalized children with confirmed influ-
enza A (pH1N1’09). In these patients, 61 complica-
tions were recorded, yielding a mean of 1.7 complica-
tions per patient, whereas 29 (45.3%) children were 
free from complications. In the post-pandemic season, 
there were 20/44 (45.5%) hospitalized children with 
44 complications, yielding a mean of 2.2 complica-
tions per patient, whereas 24 (54.5%) children had no 
complications. There was no statistically significant 
difference in the number of hospitalized children with 
complications (χ2-test=0.048, df=1, p<0.826, Fisher 
exact test) between the two seasons.
The children hospitalized during the pandemic 
season developed a greater number of viral than bacte-
rial pneumonia (10 vs. 8); in the post-pandemic sea-
son, the bacterial to viral pneumonia ratio was 10:6.
In the pandemic season, the most common compli-
cation in children was primary viral pneumonia in 10 
(15.6%) and bacterial pneumonia in eight (12.5%) 
children, followed by myositis in nine (14.0%) cases in 
the first season and seven (10.9%) cases in the second 
season. The rarest complications were otitis media and 
bronchiolitis, which occurred in two (3.1%) patients. 
The most common complication in hospitalized chil-
dren in the post-pandemic season was bacterial pneu-
monia in 10 (22.7%) cases, followed by other compli-
cations in seven (15.9%) and liver damage in five 
(11.4%) children. The rarest complications in the sec-
ond season were otitis media and acute respiratory dis-
tress syndrome, in one (2.3%) child each (Table 6).
Discussion
In our study, a smaller number of children were 
hospitalized and had a significantly lower number of 
risk factors and complications compared with adults. 
In comparison to post-pandemic season, a greater 
number of children were hospitalized during the pan-
demic season (37.9% vs. 26.4%), which is consistent 
with the reports from the UK where 36% of children 
were hospitalized in the pandemic season33,34. In our 
study, the children hospitalized in both seasons were 
significantly younger (4.5 and 3.5 years) compared to 
the results reported by Wiechinga et al. from Germany, 
where the mean age of children was seven years35. In 
both seasons, boys were more likely to acquire the dis-
ease, similar to the results reported from Germany, 
France and the United States35-37. In the pandemic sea-
son, the mean duration of illness prior to admission 
was three days, and in the post-pandemic season four 
days, which obviously resulted in longer hospital stay 
(6.0 vs. 4.0 days) in the former, particularly due to the 
development of a number of bacterial complications38. 
Therefore, in the post-pandemic season, more inflam-
matory parameters (ESR, leukocyte count, CRP), CK 
and aminotransferases and more frequent use of anti-
biotics (47.7% vs. 35.9%) were recorded. In both sea-
sons, antiviral drugs (81.8% and 67.2%) were used, 
which was similar to the results from other European 
centers35,36.
In the post-pandemic season, significantly more 
children were treated in the ICU as compared to the 
pandemic season (20.3% vs. 9.1%). The percentage of 
ICU treatment in the pandemic season was consistent 
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with the results reported by Gastañaduy and Bégué 
(9%), but higher than reported by German authors 
(6%)35,36. In the post-pandemic season, the incidence 
of severe forms of disease and mortality in hospitalized 
children was extremely low (2.3%), even in those with 
risk factors for development of complications, which 
was consistent with the reports from Spain and Chi-
na39,40. Most of our children were free from risk factors 
in both seasons (57.8% and 77.3%), as also found in 
several American and European centers41,42.
There was no significant difference in the preva-
lence of risk factors in hospitalized children, but most 
common were neuromuscular diseases (14.1% and 
4.5%), followed by asthma (9.4% and 6.8%) and dam-
age to the immune system (9.8% and 18.2%). In our 
patients, obesity was not frequent (1.5% and 2.3%), 
whereas German authors noted a greater number 
(43%) of obese children and marked obesity as an im-
portant risk factor35. The most common complication 
in children was primary viral pneumonia (15.6% vs. 
3.6%) in the first season and bacterial pneumonia (22% 
vs. 12.5%) in the second season. In our setting, there 
were complications such as encephalopathy, neurologi-
cal disorders and gastroenteritis, which are reported by 
Chen et al40. Otitis media as the most common com-
plication of influenza in children was rarely observed, 
which can be explained by the fact that pandemic in-
fluenza generally has less bacterial complications42,43. 
Unlike the US and some European reports, we had 
very few children hospitalized in both seasons and 
they had a significantly lower number of risk factors 
and complications compared with adults43.
Seasonal influenza A in children had a low mortal-
ity but high morbidity, many complications and an in-
creased number of hospitalizations, especially in chil-
dren with risk factors. In children, pandemic influenza 
presented as a mild disease with low mortality and few 
complications. Comparing with seasonal influenza, 
children infected with pandemic strain of the virus had 
more respiratory complications, a significantly higher 
number of viral and secondary bacterial pneumonia, 
and frequent need for mechanical ventilation. In chil-
dren with pandemic influenza, encephalopathy is more 
common than in seasonal influenza43. In conclusion, in 
the post-pandemic season, sick children were more 
frequently hospitalized later in the course of the dis-
ease, when bacterial complications had already devel-
oped, and hospital stay was significantly longer com-
pared to the previous season. In hospitalized children 
with evidence for pandemic influenza, the medium 
severe form of the disease prevailed, which ultimately 
meant shorter hospital stay and fewer complications. 
Complications in hospitalized children with con-
firmed influenza A (pH1N1’09) in the first two sea-
sons were not statistically significant. The most com-
mon complication of influenza in children was pri-
mary viral pneumonia in the pandemic season and 
bacterial pneumonia in the post-pandemic season. The 
rarest complication in children was otitis media in 
both seasons.
Conclusion
Children younger than 5 years, especially boys, are 
vulnerable groups for pandemic influenza. In our pa-
tients, pandemic influenza presented as a mild disease 
with low mortality and few complications. Most of the 
affected children with influenza did not have impor-
tant risk factors such as asthma and obesity, which 
other authors point out in their studies as significant 
risk factors.
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Sažetak
PANDEMIJSKA INFLUENCA A (H1N1) 2009.: BLAGA BOLEST U HOSPITALIZIRANE DJECE  
U NAJVEĆOJ KLINICI ZA INFEKTIVNE BOLESTI U HRVATSKOJ
S. Grgić, E. Čeljuska-Tošev, J. Nikolić, F. Markotić, M. Vukojević, H. Bebek-Ivanković i I. Kuzman
Pandemijski virus influence A (H1N1) 2009. uzrokuje bolest koja se epidemiološki i klinički ne razlikuje značajno od 
sezonske gripe, ali ipak postoje razlike. Cilj studije bio je prikazati i usporediti epidemiološke i kliničke karakteristike u  djece 
s dokazanim pandemijskim virusom influence A (H1N1) 2009. U Klinici za infektivne bolesti Dr. Fran Mihaljević u Zagre-
bu u prve dvije sezone incidencija pandemijskog virusa influence A (H1N1) posebno je bila iscrpno analizirana samo u 
 bolesnika s dokazanim pandemijskim virusom influence A (H1N1). U hospitalizirane djece s dokazanim pandemijskim 
 virusom influence A prevladavao je umjereni oblik bolesti, što je u konačnici značilo kraći boravak u bolnici i manje kompli-
kacija. Upala srednjeg uha je bila najrjeđa komplikacija kod djece. Zaključno, djeca mlađa od 5 godina, osobito dječaci, češće 
su obolijevali od pandemijskog virusa influence A (H1N1), koja se prezentirala kao blaža bolest s niskom smrtnošću i rjeđim 
komplikacijama. Većina oboljele djece od pandemijske influence nisu imala čimbenike rizika kao što su astma i pretilost, što 
drugi autori u svojim istraživanjima ističu kao važne čimbenike rizika za virus influence.
Ključne riječi: Influenca A virus; Podtip H1N1; Hrvatska; Rizični čimbenici; Dijete
